Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxazolone is a synthetic heterocyclic compound and functional group with the molecular formula C₁₂H₁₁NO₃ (for the commonly used immunological adjuvant form). It is primarily used in biomedical research as a haptenizing agent to induce acute or chronic inflammation in animal models—most notably for modeling colitis and atopic dermatitis. Oxazolone acts as an immunologic adjuvant and sensitizing agent by provoking Th1/Th2-dependent immune responses when applied topically or intrarectally. This leads to inflammation characterized by infiltration of T cells (notably CD4+), increased cytokine production (such as IL‑4 and TNF‑α), and tissue remodeling. The compound itself does not have direct therapeutic use in humans but is valuable for studying mechanisms of immune-mediated diseases[1][6][9]. Structurally, oxazolones are also important intermediates in organic synthesis and are present as motifs in several drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oxazolone.